Who are Salicylate ointment's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Salicylic Acid (6%), Canthardin Collodion, Neutrogena Rapid Clear®, Benzoyl Peroxide Topical, Clindamycin and BPO 5% gel, Benzoyl peroxide 5% gel.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/salicylate-ointment.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Salicylate ointment — Competitive Intelligence Brief

Salicylate ointment (Salicylate ointment) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Keratolytic agent. Area: Dermatology.

marketed Keratolytic agent Salicylic acid (acetylsalicylic acid derivative); acts on skin cell cohesion and inflammatory pathways Dermatology Small molecule Live · refreshed every 30 min

Target snapshot

Salicylate ointment (Salicylate ointment) — Assistance Publique - Hôpitaux de Paris. Salicylate ointment works by penetrating the skin to deliver salicylic acid, which exfoliates and removes dead skin cells while reducing inflammation and promoting healing.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Salicylate ointment TARGET	Salicylate ointment	Assistance Publique - Hôpitaux de Paris	marketed	Keratolytic agent	Salicylic acid (acetylsalicylic acid derivative); acts on skin cell cohesion and inflammatory pathways
Salicylic Acid (6%)	Salicylic Acid (6%)	Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh	marketed	Keratolytic agent
Canthardin Collodion	Canthardin Collodion	Medical University of South Carolina	marketed	Vesicant / keratolytic agent	Protein phosphatase 2A (PP2A)
Neutrogena Rapid Clear®	Neutrogena Rapid Clear®	GlaxoSmithKline	marketed	Topical antimicrobial/keratolytic agent	Cutibacterium acnes (bacterial cell membranes and proteins)
Benzoyl Peroxide Topical	Benzoyl Peroxide Topical	University of Missouri-Columbia	marketed	Topical antimicrobial and keratolytic agent
Clindamycin and BPO 5% gel	Clindamycin and BPO 5% gel	Stiefel, a GSK Company	marketed	Topical antibiotic combination with keratolytic agent	Bacterial 50S ribosome (clindamycin); oxidative damage to bacterial cell membranes (BPO)
Benzoyl peroxide 5% gel	Benzoyl peroxide 5% gel	University of Southern California	marketed	Topical antimicrobial and keratolytic agent

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Keratolytic agent class)

Assistance Publique - Hôpitaux de Paris · 1 drug in this class
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Salicylate ointment — Competitive Intelligence Brief. https://druglandscape.com/ci/salicylate-ointment. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab